|Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases|
AB Kunnumakkara, D Bordoloi, G Padmavathi, J Monisha, NK Roy, ...
British journal of pharmacology 174 (11), 1325-1348, 2017
|Possible use of Punica granatum (Pomegranate) in cancer therapy|
AD Khwairakpam, D Bordoloi, KK Thakur, J Monisha, F Arfuso, G Sethi, ...
Pharmacological research 133, 53-64, 2018
|Tocotrienols: The promising analogues of vitamin E for cancer therapeutics|
BL Sailo, K Banik, G Padmavathi, M Javadi, D Bordoloi, ...
Pharmacological research 130, 259-272, 2018
|Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far|
D Bordoloi, N K Roy, J Monisha, G Padmavathi, A B Kunnumakkara
Recent patents on anti-cancer drug discovery 11 (1), 67-97, 2016
|Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression|
G Padmavathi, K Banik, J Monisha, D Bordoloi, B Shabnam, F Arfuso, ...
Cancer letters 432, 260-271, 2018
|Potential of zerumbone as an anti-cancer agent|
S Girisa, B Shabnam, J Monisha, L Fan, CE Halim, F Arfuso, KS Ahn, ...
Molecules 24 (4), 734, 2019
|Potential of butein, a tetrahydroxychalcone to obliterate cancer|
G Padmavathi, SR Rathnakaram, J Monisha, D Bordoloi, NK Roy, ...
Phytomedicine 22 (13), 1163-1171, 2015
|NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance|
J Monisha, NK Roy, G Padmavathi, K Banik, D Bordoloi, AD Khwairakpam, ...
Cancers 10 (7), 228, 2018
|Specific targeting of Akt kinase isoforms: Taking the precise path for prevention and treatment of cancer|
N Kishor Roy, D Bordoloi, J Monisha, G Padmavathi, J Kotoky, R Golla, ...
Current drug targets 18 (4), 421-435, 2017
|TIPE family of proteins and its implications in different chronic diseases|
D Bordoloi, K Banik, B Shabnam, G Padmavathi, J Monisha, F Arfuso, ...
International journal of molecular sciences 19 (10), 2974, 2018
|NF-κB blockers gifted by mother nature: Prospectives in cancer cell chemosensitization|
J Monisha, G Padmavathi, NK Roy, A Deka, D Bordoloi, A Anip, ...
Current pharmaceutical design 22 (27), 4173-4200, 2016
|Nuclear factor kappa B: a potential target to persecute head and neck cancer|
J Monisha, N Kishor Roy, D Bordoloi, A Kumar, R Golla, J Kotoky, ...
Current drug targets 18 (2), 232-253, 2017
|Anticancer activity of Garcinia morella on T-cell murine lymphoma via apoptotic induction|
B Choudhury, R Kandimalla, R Bharali, J Monisha, AB Kunnumakara, ...
Frontiers in pharmacology 7, 3, 2016
|Sorcin a potential molecular target for cancer therapy|
B Shabnam, G Padmavathi, K Banik, S Girisa, J Monisha, G Sethi, L Fan, ...
Translational oncology 11 (6), 1379-1389, 2018
|The vital role of ATP citrate lyase in chronic diseases|
AD Khwairakpam, K Banik, S Girisa, B Shabnam, M Shakibaei, L Fan, ...
Journal of Molecular Medicine 98 (1), 71-95, 2020
|Acorus calamus: a bio-reserve of medicinal values|
AD Khwairakpam, YD Damayenti, A Deka, J Monisha, NK Roy, ...
Journal of basic and clinical physiology and pharmacology 29 (2), 107-122, 2018
|Isoform-specific role of akt in oral squamous cell carcinoma|
NK Roy, J Monisha, G Padmavathi, H Lalhruaitluanga, NS Kumar, ...
Biomolecules 9 (7), 253, 2019
|An investigation on the therapeutic potential of butein, a tretrahydroxychalcone against human oral squamous cell carcinoma|
D Bordoloi, J Monisha, M Roy, G Padmavathi, K Banik, C Harsha, H Wang, ...
Asian Pacific journal of cancer prevention: APJCP 20 (11), 3437, 2019
|TIPE2 induced the proliferation, survival, and migration of lung cancer cells through modulation of Akt/mTOR/NF-κB signaling cascade|
D Bordoloi, K Banik, G Padmavathi, R Vikkurthi, C Harsha, NK Roy, ...
Biomolecules 9 (12), 836, 2019
|Vietnamese coriander inhibits cell proliferation, survival and migration via suppression of Akt/mTOR pathway in oral squamous cell carcinoma|
AD Khwairakpam, J Monisha, NK Roy, D Bordoloi, G Padmavathi, K Banik, ...
Journal of basic and clinical physiology and pharmacology 31 (3), 2020